U.S. Department of Veterans Affairs Begins National Rollout of WCG’s IRBNet
WCG announced that the U.S. Department of Veterans Affairs’ (VA) Office of Research and Development is successfully implementing WCG’s IRBNet electronic submission and review system for more than 100 VA medical centers (VAMCs) that have research programs.
In 2019, the VA selected IRBNet over other available solutions as the best solution to meet its complex research and compliance needs on an enterprise scale and to standardize processes among all sites. IRBNet provides technology-supported workflow, communication and documentation capabilities, assisting IRB compliance with ethical and regulatory standards for the inclusion of appropriate human subject protections, and the oversight of study conduct as mandated by federal guidelines.
“We are delighted that all the VA sites will now be using IRBNet. We specifically designed the platform to facilitate IRB compliance and increase productivity,” said Jeremy Katz, President, WCG IRBNet. “By reducing VA IRB staff’s administrative burden, IRBNet allows them to devote more time to other high priority activities, such as training and protocol development.”
For more information, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
